Intronic

TP53 glioblastoma prostate cancer rs1042522 rs9895829 and rs2909430 single nucleotide polymorphism Δ133p53

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
01 Sep 2020
Historique:
received: 07 08 2020
revised: 26 08 2020
accepted: 28 08 2020
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: epublish

Résumé

We investigated the influence of selected

Identifiants

pubmed: 32882831
pii: cancers12092472
doi: 10.3390/cancers12092472
pmc: PMC7563340
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Health Research Council of New Zealand
ID : 15/500
Organisme : Health Research Council CDA Slatter
ID : 16/054
Organisme : HRC Emerging First Researcher Grant Mehta
ID : 20/638
Organisme : Cancer Society of New Zealand Drummond
ID : 18.11
Organisme : Marsden Fund
ID : UOO1903
Organisme : Cancer Institute NSW
ID : CDF181205
Organisme : Australian Cancer Council NSW
ID : PG11-08

Références

J Gastroenterol. 2007 Jun;42(6):456-60
pubmed: 17671760
Cold Spring Harb Perspect Med. 2016 Aug 01;6(8):
pubmed: 27329033
J Pathol. 2018 Sep;246(1):77-88
pubmed: 29888503
PLoS One. 2011 Jan 20;6(1):e15813
pubmed: 21283750
J Mol Biol. 2016 Jun 19;428(12):2623-2635
pubmed: 27107644
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):214-22
pubmed: 17301252
Cancer Res. 2017 Mar 15;77(6):1250-1260
pubmed: 28254861
Cancer Genet Cytogenet. 2010 Mar;197(2):174-8
pubmed: 20193851
Oncol Lett. 2012 Mar;3(3):599-606
pubmed: 22740959
Mod Pathol. 2016 Mar;29(3):212-26
pubmed: 26769142
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Commun. 2018 Jan 17;9(1):254
pubmed: 29343721
Prostate. 2010 Dec 1;70(16):1739-45
pubmed: 20593380
Lancet. 2003 Mar 8;361(9360):836-8
pubmed: 12642053
Eur J Cancer. 2009 Jun;45(9):1664-72
pubmed: 19318244
Cancer Res. 2010 Jul 15;70(14):5851-9
pubmed: 20587514
Front Oncol. 2016 Jan 21;5:306
pubmed: 26835415
Science. 1990 Nov 30;250(4985):1233-8
pubmed: 1978757
Cancers (Basel). 2020 Mar 24;12(3):
pubmed: 32213968
Bioinformatics. 1999 Jul-Aug;15(7-8):622-30
pubmed: 10487870
Nature. 1992 Mar 19;356(6366):215-21
pubmed: 1552940
Int J Cancer. 2007 Oct 1;121(7):1481-6
pubmed: 17546594
Nat Genet. 2000 May;25(1):47-54
pubmed: 10802655
Nat Genet. 2003 Mar;33(3):357-65
pubmed: 12567188
Elife. 2016 Sep 15;5:
pubmed: 27630122
Int J Mol Sci. 2017 Jul 17;18(7):
pubmed: 28714919
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8
pubmed: 12496062
Cell. 2018 Apr 5;173(2):371-385.e18
pubmed: 29625053
Oncogene. 2006 Jun 15;25(25):3489-500
pubmed: 16462765
Cell Death Differ. 2011 Feb;18(2):248-58
pubmed: 20689555
Mamm Genome. 2018 Dec;29(11-12):831-842
pubmed: 29992419
Front Oncol. 2019 Sep 11;9:885
pubmed: 31572679
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1840-7
pubmed: 20615891
Acta Diabetol. 2013 Jun;50(3):429-36
pubmed: 23269546
Sci Rep. 2017 May 8;7(1):1566
pubmed: 28484276
Int J Cancer. 2004 Jan 10;108(2):196-9
pubmed: 14639602
Hum Mutat. 2010 Apr;31(4):456-65
pubmed: 20127977
Mol Cell Biol. 1999 Feb;19(2):1092-100
pubmed: 9891044
Br J Cancer. 2007 Aug 6;97(3):277-82
pubmed: 17637683
Cancer Res. 2016 Dec 15;76(24):7151-7159
pubmed: 27913434
Semin Cancer Biol. 2010 Feb;20(1):57-62
pubmed: 20206267
Breast Cancer Res Treat. 2010 Apr;120(2):509-17
pubmed: 19629678
Hum Genet. 2009 Oct;126(4):559-65
pubmed: 19521721
Cancer Cell. 2003 Apr;3(4):387-402
pubmed: 12726864
Cancer Res. 2006 Jul 1;66(13):6473-6
pubmed: 16818615
Curr Protoc Bioinformatics. 2014 Jun 17;46:12.6.1-25
pubmed: 24939127
Neoplasma. 2000;47(5):303-6
pubmed: 11130248
Clin Exp Rheumatol. 2009 Jul-Aug;27(4):615-9
pubmed: 19772793
Cell Death Dis. 2019 Aug 20;10(9):631
pubmed: 31431617
Carcinogenesis. 2014 Mar;35(3):586-96
pubmed: 24336193
J Med Virol. 2008 Mar;80(3):424-9
pubmed: 18205229
Oncogene. 2010 May 6;29(18):2691-700
pubmed: 20190805
Nat Rev Cancer. 2009 Feb;9(2):95-107
pubmed: 19165225
Genes Dev. 2005 Sep 15;19(18):2122-37
pubmed: 16131611
Mutagenesis. 2003 Jul;18(4):377-85
pubmed: 12840112
AJNR Am J Neuroradiol. 2018 Feb;39(2):252-259
pubmed: 29191871

Auteurs

Ramona A Eiholzer (RA)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Sunali Mehta (S)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.

Marina Kazantseva (M)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.

Catherine J Drummond (CJ)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.

Cushla McKinney (C)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Katie Young (K)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

David Slater (D)

Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.
Hunter Medical Research Institute, New South Wales 2305, Australia.

Brianna C Morten (BC)

Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.
Hunter Medical Research Institute, New South Wales 2305, Australia.

Kelly A Avery-Kiejda (KA)

Priority Research Centre for Cancer Research, Innovation and Translation and the Hunter Cancer Research Alliance, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, New South Wales 2305, Australia.
Hunter Medical Research Institute, New South Wales 2305, Australia.

Annette Lasham (A)

Department of Molecular Medicine and Pathology, University of Auckland, Auckland 1023, New Zealand.

Nicholas Fleming (N)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Helen R Morrin (HR)

Department of Pathology and Biomedical Science, University of Otago, Christchurch 8140, New Zealand.

Karen Reader (K)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Janice A Royds (JA)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Michael Landmann (M)

Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.

Simone Petrich (S)

Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin 9054, New Zealand.

Roger Reddel (R)

Children's Medical Research Institute, University of Sydney, Westmead, New South Wales 2145, Australia.

Lily Huschtscha (L)

Children's Medical Research Institute, University of Sydney, Westmead, New South Wales 2145, Australia.

Ahmad Taha (A)

Department of Neurosurgery, Southern District Heath Board, Dunedin 9016, New Zealand.

Noelyn A Hung (NA)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.

Tania L Slatter (TL)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.

Antony W Braithwaite (AW)

Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Maurice Wilkins Centre for Molecular Biodiscovery, Dunedin 9016, New Zealand.
Malaghan Institute of Medical Research, Wellington 6242, New Zealand.

Classifications MeSH